The president of an animal shelter writes about her dog in hopes to help children:
"The head of KCMO animal shelter Wayside Waifs hopes the story of her Golden Retriever's victory over cancer helps children who have cancer themselves.
Cynthia Smith's new children's book, Dogs Get Cancer Too, tells of her dog Wishbone's battle with lymphoma, which began after a swollen lymph node was discovered in his neck during a bath.
"Week after week for five months, Wishbone spent the day at the hospital, and just like a human cancer patient, he waited patiently while his IV drip drained into his body," Smith said. "He displayed all the side effects you would expect: loss of appetite and energy--and yes, he lost some hair."
Smith got good news in December 2008 when Wishbone's veterinarian said the dog was free of cancer. Wishbone lived on until the beginning of this year, when time finally caught up with him, and he died at the old age of 13."
Read More: http://www.examiner.com/dogs-in-kansas-city/wayside-waifs-president-writ...
Amazon.com is pleased to have the Lymphoma Information Network in the family of Amazon.com associates. We've agreed to ship items...
The question ought to be what are myelodysplastic syndromes (MDS), since this is a group of similar blood and bone marrow diseases that...
Merkel Cell Carcinoma (MCC) is a very rare and aggressive skin cancer that usually develops when a person is in his or her 70s. It is...
At some point, the Seattle biotech company Cell Therapeutics Inc (CTI) should earn an entry in the Guinness Book of World Records for utter and...
This site was started as Lymphoma Resource Page(s) in 1994. The site was designed to collect lymphoma...
Three papers appearing in the journal Blood and pointing towards a regulator-suppressor pill could offer hope to blood cancer...
The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...
The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...
The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...
According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...
Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...
New research suggests that frontline radioimmunotherapy...
Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...